Analysis of the major histocmpatibility complex class II gene promoter DRA has previously identified at least five cis-acting regions required for maximal expression. We have exmned the DRA promoter for protein-DNA interactions in the intact cell, which may mediate transcriptional activation. Using in vivo genomic footprinting we identified interactions in B-cell lines at the octamer site and the Y, Xl, and X2 boxes. Class H antigen expressing T-ceD lines maintained contacts identical to B-cell lines, while class li-negative T-ceDf lines exhibited no interactions. In lymphoid cell lines, the octamer site is occupied and required for maximal expression. This is most likely due to the presence of the lymphoid-specific OTF-2 factor. In contrast, the class iI-positive nonlymphoid glioblastoma cell line does not exhibit interactions at the octamer site despite the presence ofthe ubiquitous OTF-1 factor and an open binding site. Thus, the DRA promoter discriminates ag st OTF-1 activation at the level of DNA binding in the glioblastoma line. Interferon y induces class H expression in this gabla cell line and, in parallel, up-regulates X1 and X2 box protein-DNA interactions, while all other interactions remain unchanged. These results suggest that interferon y functions on a poised promoter by altering weak, nonproductive interactions at the X boxes to strong interactions. These findis provide direct in vivo evidence to strongly suggest that the modulation of X1 and X2
interactions. In lymphoid cell lines, the octamer site is occupied and required for maximal expression. This is most likely due to the presence of the lymphoid-specific OTF-2 factor. In contrast, the class iI-positive nonlymphoid glioblastoma cell line does not exhibit interactions at the octamer site despite the presence ofthe ubiquitous OTF-1 factor and an open binding site. Thus, the DRA promoter discriminates ag st OTF-1 activation at the level of DNA binding in the glioblastoma line. Interferon y induces class H expression in this gabla cell line and, in parallel, up-regulates X1 and X2 box protein-DNA interactions, while all other interactions remain unchanged. These results suggest that interferon y functions on a poised promoter by altering weak, nonproductive interactions at the X boxes to strong interactions. These findis provide direct in vivo evidence to strongly suggest that the modulation of X1 and X2
interactions is an important constituent of the interferon v induction pathway.
The major histocompatibility complex (MHC) class II molecules play a central role in the immune response. MHC class II molecules can present antigen on the surface of cells, which is then recognized by the T-cell receptor of class IT-restricted T cells (1, 2) . This interaction leads to an activation ofT cells and the initiation of an immune response. The intensity of the response is modulated by the level of MHC class II molecules on the cell surface (3, 4) . Specific haplotypes of class II have been linked to several autoimmune diseases (5) . Thus, a detailed investigation of the regulation of MHC class TI antigen expression is critical to our understanding of the immune response and immune system dysfunction. Class H molecules are expressed on a select group of cell types including B cells, dendritic cells, thymic epithelial cells, skin Langerhans cells, liver Kupffer cells, brain glial cells (6) (7) (8) , and activated macrophages and T cells (9) (10) (11) (12) . Cytokines such as interferon y (IFN-y) can induce class II expression in a small number of class IInegative cell types (13) (14) (15) (16) . In most cases, class II expression is regulated primarily at the level of transcription, prompting extensive study of the promoter regions and in particular the HLA-DRA promoter.
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Two highly conserved promoter domains termed the X and Y boxes lie within the proximal promoter region of class II genes (17) . These elements are critical for optimal class II gene expression (18) (19) (20) (21) . The X box interacts in vitro with at least two proteins, RF-X and hXBP-1. RF-X binds over the 5' end of the X box (X1) and has aberrant binding in cells from patients with the bare lymphocyte syndrome (22, 23) . hXBP-1 binds at the 3' end of the X box (X2) and has homology to Fos and Jun (24) . Functional analysis with site-specific mutations has indicated that both X1 and X2 are important for the constitutive level of transcription and XI is involved in IFN-y inducibility (24, 25) . The Y box contains an inverted CCAAT motifwith which several proteins have been shown to interact in vitro. YEBP was partially purified in our laboratory from B-cell extracts and activates the DRA promoter in vitro (20) . YEBP may be the human analog to the murine NF-Y A/B (26, 27) . YB-1 was cloned from an expression library and, while its DNA recognition site is similar to those of YEBP and NF-Y, the expression of YB-i is inversely correlated to the level of class II expression, implying a potential role as a negative regulator (28) . In addition to the X and Y boxes, the DRA promoter is unique within the class II family in the presence of an octamer binding site between the Y and TATA boxes. This site is functionally required in B cells but not in most nonlymphoid cell types (18, 29, 30) . In addition, a lessconserved functional domain, W, lies upstream of the X box. Functional analysis of this region has identified a Servenius sequence (S), which is required for IFN-y responsiveness (31) (32) (33) .
In vitro protein-DNA studies are limited because they may not accurately reflect the in vivo state of promoter interactions. The recent improvement of the in vivo genomic footprinting procedure (34) permits analysis of protein-DNA interactions in intact cells. This report utilizes in vivo genomic footprinting to confirm initial findings in B cells (35) and expands it to class II-positive and class II-negative T-cell lines. Analysis of an inducible, nonlymphoid cell line revealed the selective lack of interaction at the octamer site despite the high levels of class II antigens. H9 (HuT78) was derived from a human cutaneous T-cell lymphoma and constitutively expresses class II antigens. HSB and Jurkat are T-lymphoblastoid cell lines (T-LCLs) that cannot be induced to express class II antigens. U373-MG is a glioblastoma multiform cell line (36) . The human recombinant IFN-y was a generous gift of Biogen. The wild-type DRA promoter-chloramphenicol acetyltransferase (CAT) fusion construct (5'A-152 WT) has been described (33) . The 5'A-152 MUTocta construct was generated by site-directed mutagenesis (37) and altered octamer motif from 5'-TTGATTTGCAT-3' to 5'-TTGcgggt-CAT-3'.
In VivoFootprinting. In vivo methylation of cells and DNA preparation were as described by Pfeifer et al. (38) . The ligation-mediated, PCR-amplified, in vivo genomic footprinting was as described by Mueller and Wold (34) RESULTS A number of cis-acting DNA elements within the proximal 150 base pairs of the DRA promoter have been previously described (see Fig. 2 ). This report directly assays the protein-DNA interactions at the endogenous DRA promoter by in vivo genomic footprinting.
In Vivo, the DRA Promoter Maintains Protein-DNA Interactions Across the Class I Box and at the Octamer Site in Class II-Expressing B-Lymphoblastoid Cells. Most functional analysis of the DRA promoter has been performed in B-lymphoblastoid cell lines (B-LCLs), which constitutively express high levels of class II antigen. Thus, we chose to initially examine the in vivo protein-DNA interactions in the B-LCLs Raji and Namalwa. In vivo genomic footprinting reveals the close association ofprotein with DNA in the intact cell by the protection or enhancement ofdimethyl sulfate methylation of guanine residues (34, 41) . These protections or enhancements are then displayed as alterations in the intensity of specific bands in the guanine sequence ladder as compared to deproteinized DNA.
Class II antigen expressing B-LCLs displayed a series of guanine contact points on both the upper and lower strand of the DRA promoter ( Fig. 1 ; summarized in Fig. 2 ). Both Raji and Namalwa cells revealed identical patterns of interaction. Two protections on the upper strand at -48 and -53 and one on the lower strand at -47 are located at the octamer consensus sequence. The lower-strand protection was significantly weaker (40-50%o protection in Namalwa cells); however, it was highly reproducible through several (>5) independent experiments. The octamer sequence is required for maximal expression of DRA in B cells (see below and ref. 29) . A doublet of protected guanine residues at -67 and -68 AA. §ACTA G TTCTCAAACTAAACG- (Table 1) . However, in U373-MG cells mutation of the octamer site did not result in a loss of promoter function but instead caused a minimal (<2-fold) increase in activity. Thus, the functional importance ofthe octamer site parallels its in vivo occupancy. A family of transcription factors (OTF) has been identified that binds to the octamer consensus (45) . Nuclear extracts from Raji, H9, and U373-MG cells were subjected to a gel mobility-shift assay with a DRA octamer probe to resolve the OTF family (Fig. 4) . The most intense band (band A) corresponds to the ubiquitous OTF-1 factor, according to Gerster et al. (40) , and is present in each cell line. Thus, the lack of in vivo binding in the U373-MG cells suggests that OTF-1 is discriminated against by the endogenous DRA promoter structure in this cell line. A second band (band B), most likely representing the lymphoid-specific OTF-2 factor, is present at high levels in Raji cells. Interestingly, in H9 nuclear extracts a weak but detectable complex comigrates with this band (band B). However, this band is absent in the U373-MG cell extracts. The availability of this factor directly corre- sponds to the in vivo occupancy of the octamer site and provides further credence implicating OTF-2 as the functional factor activating DRA transcription.
ION-y Induction of Class II Expression in a Glioblastoma
Cell Line Is Paralleled by an Up-Regulation of in Vivo Binding at the X1 and X2 Boxes. Before IFN-y induction, a second distinction was observed between B-LCLs and the U373-MG cell line. The guanine residues within the X1 and X2 motifs were partially visible in the in vivo 0-hr sample (Fig. 3) . This is most clearly revealed on the lower strand. The intensity of the X region guanine bands is only reduced by =60% compared to the deproteinized control DNA. In contrast, in the B-LCLs there was a complete protection of the X1 and X2 regions. Contact points in the Y box and upstream region were similar between the lymphoid and glioblastoma cell lines. IFN-y treatment of the U373-MG cell line induces a peak of mRNA accumulation at 18-24 hr, which is primarily controlled at the transcriptional level (46, 47) . At 4 hr, no changes in the in vivo footprint are observed. However, concomitant with the up-regulation of class II transcription, the in vivo footprint of the X region at 18 and 48 hr revealed a change to complete protection of all of the X region guanine residues (Fig. 3) . The up-regulation of in vivo interaction at the X region makes this region indistinguishable from the class II-expressing lymphoid cell lines. (35) . Their results with the DRA gene identified promoter interactions at the octamer site and the Y, X1, and X2 boxes. In addition, they found a lack of all interactions in class II-deficient mutant cell lines derived from certain bare lymphocyte syndrome patients. In this report, we have extensively expanded these initial studies in B-cell lines to include class II-positive and -negative T-cell lines and an IFN-y inducible, nonlymphoblastoid cell line.
DISCUSSION
In B-LCLs and a class II-positive T-LCL, the octamer site was occupied. This occupancy is most likely associated with the presence of OTF-2 in lymphoid cells, although the possibility that OTF-1 occupies this site in conjunction with other lymphoid-specific factors cannot be excluded at this time. In contrast, the octamer site was vacant in the nonlymphoid, glioblastoma cell line. This finding agrees with the functional analysis showing a requirement for these sequences in B-LCLs and a class II-positive T-LCL but not in the glioblastoma cells (Table 1 and ref. 29) . The slight increase in activity seen in the glioblastoma cells upon mutation of the octamer site may suggest an uncharacterized repressive role for this site in nonlymphoid class II-positive cells. The apparent vacancy of the octamer site in the glioblastoma cell occurs despite the availability of the ubiquitous OTF-1 factor. Furthermore, the lack of octamer binding is apparently not due to differences in the adjacent interactions, since all of the neighboring contact points are the same between the lymphoid and nonlymphoid cells. These results provide the first direct evidence that in vivo the OTF-1 binding interaction is selectively excluded in a functional promoter. One explanation for the exclusion may be inappropriate contacts between OTF-1 and the other transacting factors present on the promoter in this cell line. At present, it is unclear whether the exclusion of octamer occupancy is unique to the glioblastoma cell line or is common to all nonlymphoid class TI-positive cells.
The in vivo protein-DNA interactions at the Y box and the Xi and X2 boxes confirm the functional data defining each of these elements as required for optimal class TI expression. In B-LCLs and class II-positive T-LCLs, the X boxes were extensively protected. The contact points are clustered into two groups. One group lies within the X2 motif with single hypersensitive guanine residues immediately flanking each side of the X2 box, suggesting these may be the boundaries of the X2 interaction. The second cluster lies at the 5' end of the Xi box corresponding to the putative RF-X interaction domain. A single unprotected guanine residue between the two groups suggests that the Xi and X2 boxes are separate and distinct binding events. The hypersensitive adenosine residue appearing approximately midway between the X and the Y boxes suggests that this region of the DNA structure may be distorted-for example, by DNA bending. This is compatible with a previous study, which demonstrated a functional requirement for the stereospecific alignment ofthe X and Y boxes that was independent of the absolute distance between the two domains (48) . This suggests that the X and Y box factors are able to bend the intervening DNA to come in direct or indirect contact. In addition, the hypersensitivity occurs only in the presence of X and Y box protein-DNA interactions, suggesting that the putative DNA bend may be driven by the protein-protein contacts or, alternatively, by protein-DNA contacts.
The glioblastoma cell line U373-MG can be induced by IFN-yto express high levels of class 11 (15, 32) . Before IFN-,y induction, the interactions at the X1 and Xi boxes are weak compared to B-LCLs. Concomitant with the induction of DRA transcription, the X box interactions increase in intensity to levels indistinguishable from B cells. No other changes are detected during the induction. Identical results were obtained with the melanoma cell line Thayer, which are induced to -80%o class II-positive by IFN-y. These results Proc. NatL Acad Sci. USA 89 (1992) .0- 4- indicate that in an inducible cell the DRA gene is poised for expression with the majority of protein-DNA interactions in place. However, the X box interactions are weak and potentially nonproductive. IFN-y may induce a modification ofthe existing X box interactions to make the binding productive or, alternatively, induce new protein-DNA interactions. Recent results have confirmed an increase in X box binding in vitro in primary rat astrocytes (33) . Interestingly, no contact points directly attributable to the S site were detected. Functional analysis of the IFN-y induction has demonstrated a requirement for the S site. It is possible that the S interaction escapes detection by the in vivo footprinting technique. Alternatively, the S domain may be the site of a transient binding activity only required in the initial stages of the IFN-y response. A transient interaction has been recently demonstrated for the overlapping IFN-a/y response site in the gene of the guanylate-binding protein (49) .
In contrast to the poised promoter detected in the glioblastoma cell line prior to induction, the class II-negative T-LCLs displayed no protein-DNA interactions. Class II-negative T-LCLs cannot be induced to express DRA and thus do not maintain a poised promoter. Down-regulation of transcription through prevention of all interactions at the promoter, perhaps by reordering the chromatin structure, would be an effective mechanism to down-regulate the entire class II locus.
In summary, B-and T-lymphoid cells expressing the class II DRA gene, maintain constitutive protein-DNA interactions at the octamer site and the Y, Xi, and X2 boxes. However, the octamer site is not occupied in the nonlymphoid cell line in congruence with lymphoid-specific function of this site. In addition, there is a dynamic up-regulation of X box binding in parallel with the induction of expression by IFN-y in class II-inducible cell lines.
